Angiotensin 1 receptor antagonist attenuates acute kidney injury-induced cognitive impairment and synaptic plasticity via modulating hippocampal oxidative stress

被引:10
作者
Sharifi, Fatemeh [1 ]
Reisi, Parham [1 ]
Malek, Maryam [1 ]
机构
[1] Isfahan Univ Med Sci, Sch Med, Dept Physiol, Esfahan, Iran
关键词
AT1R; Ang II; AKI; Synaptic plasticity; Hippocampus; Learning and memory; Losartan; BRAIN-BARRIER PERMEABILITY; NITRIC-OXIDE; MEMORY DYSFUNCTION; CROSS-TALK; LOSARTAN; ISCHEMIA; BLOCKADE; INFLAMMATION; REPERFUSION; PREVENTS;
D O I
10.1016/j.lfs.2019.116775
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aims: The activation of the angiotensin (Ang) II after acute kidney injury (AKI) triggers oxidative stress and inflammatory cascade which involved not only the kidneys but also the brain. Ang II through the Ang II type 1 receptor (AT1R) may have deleterious effects on hippocampal synaptic transmission and cognitive functions under uremic encephalopathy. The present study was conducted to examine the effects of AT1R antagonist on AKI-induced cognitive and synaptic plasticity impairment. Main methods: Here, we investigated the effect of AKI and possible pathophysiological roles of AT1R with the selective AT1R antagonist losartan (10 mg/kg/day for consecutive 9 days) on cognitive performance using passive avoidance and Morris water maze tests. In order to understand the synaptic transmission, in vivo short and long-term plasticity were evaluated at the Schaffer collateral-CA1 synapse. Biochemical analysis was also performed to detect possible hippocampal nitric oxide and oxidative stress mechanisms. Key findings: Our data provide evidence of hippocampal complication following AKI with increased level of nitrite (P < 0.01 vs. sham) as well as oxidative stress (P < 0.01 vs. sham) that may be responsible for behavioral dysfunction under uremia (spatial memory, P < 0.001; passive avoidance P < 0.01 vs. sham). Losartan treatment effectively protects against cognitive (spatial memory, P < 0.01; passive avoidance P < 0.05 vs. AKI-veh) and synaptic plasticity impairments induced by AKI possibly via modulation of oxidative stress in the hippocampus (P < 0.01 vs. AKI-veh). Significance: The present study conclusively demonstrated a protective role of AT1R antagonist losartan in hippocampal complication and neurocognitive dysfunction after AKI via modulating oxidative stress.
引用
收藏
页数:8
相关论文
共 71 条
[1]   RAS modulation prevents progressive cognitive impairment after experimental stroke: a randomized, blinded preclinical trial [J].
Ahmed, Heba A. ;
Ishrat, Tauheed ;
Pillai, Bindu ;
Fouda, Abdelrahman Y. ;
Sayed, Mohammed A. ;
Eldahshan, Wael ;
Waller, Jennifer L. ;
Ergul, Adviye ;
Fagan, Susan C. .
JOURNAL OF NEUROINFLAMMATION, 2018, 15
[2]   Incidence and outcomes in acute kidney injury: A comprehensive population-based study [J].
Ali, Tariq ;
Khan, Izhar ;
Simpson, William ;
Prescott, Gordon ;
Townend, John ;
Smith, William ;
MacLeod, Alison .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (04) :1292-1298
[3]   Localization and function of angiotensin AT1 receptors [J].
Allen, AM ;
Zhuo, JL ;
Mendelsohn, FAO .
AMERICAN JOURNAL OF HYPERTENSION, 2000, 13 (01) :31S-38S
[4]   Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats [J].
Ando, H ;
Zhou, J ;
Macova, M ;
Imboden, H ;
Saavedra, JM .
STROKE, 2004, 35 (07) :1726-1731
[5]   Angiotensin II blockade of long-term potentiation at the perforant path-granule cell synapse in vitro [J].
Armstrong, DL ;
Garcia, EA ;
Ma, T ;
Quinones, B ;
Wayner, MJ .
PEPTIDES, 1996, 17 (04) :689-693
[6]   Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation [J].
Benicky, Julius ;
Sanchez-Lemus, Enrique ;
Honda, Masaru ;
Pang, Tao ;
Orecna, Martina ;
Wang, Juan ;
Leng, Yan ;
Chuang, De-Maw ;
Saavedra, Juan M. .
NEUROPSYCHOPHARMACOLOGY, 2011, 36 (04) :857-870
[7]   ADMA and oxidative stress may relate to the progression of renal disease:: rationale and design of the VIVALDI study [J].
Böger, RH ;
Schwedhelm, E ;
Maas, R ;
Quispe-Bravo, S ;
Skamira, C .
VASCULAR MEDICINE, 2005, 10 :S97-S102
[8]  
Bucurescu G., 2016, MED SCAPE
[9]   Neurology and the kidney [J].
Burn, DJ ;
Bates, D .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 65 (06) :810-821
[10]   Long-term anti-proteinuric effect of Losartan in renal transplant recipients treated for hypertension [J].
Calviño, J ;
Lens, XM ;
Romero, R ;
Sánchez-Guisande, D .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (01) :82-86